Financial toxicity in GU Oncology, with Dr David Penson

13th May 2021

Today Declan and Renu recall one of the highlights of ASCO GU 2020 (the last real physical meeting!!), when Dr David Penson delivered his keynote address on financial toxicity in GU Oncology. David's team also followed up with a fantastic systematic review on this completely under-discussed topic in European Urology Oncology recently (link below). David is Professor and Chair of Urology at Vanderbilt University Medical Centre in Nashville, and has had a distinguished career investigating quality of life in prostate cancer patients, particularly as PI of the Prostate Cancer Outcomes Study. No holds barred today as we discuss everything from bankruptcy-free survival to the ludicrous lack of support for de-escalation studies in GU Oncology. Plus of course, we indulge his love of golf for just a bit.

Links:
David Penson Twitter (Urogeek) - highly recommended!
Recent systematic review on financial toxicity in Eur Urol Oncol
Urotoday coverage of David's ASCO GU 2020 talk
Stacey Dusetzina twitter
Royal Portrush GC (in memory of Jimmy Penson, a proper golfer!)

Previous
Previous

Post-ASCO VISION deep dive - with Dr Mike Morris

Next
Next

PCF Global Prostate Ca Webinar - TheraP trial